NCT06701981尚未招募不适用
Etude De L'Effet De Filtres Sur L'Eblouissement D'Inconfort
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Light discomfort thresholds
研究概览
简要总结
The goal of this clinical trial is to evaluate the glare protection provided by two filters compared to no filter. Using the Lumiz 100™ device (a headset with gradually increasing light), participants will measure their discomfort thresholds under three different conditions (one per filter). Each measurement will be repeated three times. The study requires a single visit of 2 hours for each participant. Glare protection will be quantified by comparing discomfort thresholds across the no-filter condition and the two studied filters.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •A willing person, fluent in French, inclined to follow protocol, capable of reading and understanding the information form, and able to give their free and informed consent.
- •Beneficiary of the French Social Security system
- •Aged 18 to 65 years
- •No or moderate ocular correction (Spherical prescription for distance vision: in the range [-8.00 to +6.00 D]* (negative cylinder) for each eye; Cylindrical prescription for distance vision: in the range [0 to -4.00 D] for each eye; Anisometropia ≤ 2.00 D on the equivalent sphere)
- •Correct vision with prescription glasses (Corrected visual acuity +0.10 logMAR or better (distance vision / high contrast / photopic luminance)
- •Regular user of sunglasses at least in bright light conditions
排除标准
- •Age < 18 years (i.e., no minors in accordance with Article L1121-7 of the Public Health Code of "Code de Santé Publique")
- •Pregnant, parturient, or breastfeeding women (Article L1121-5 of the Public Health Code of "Code de Santé Publique")
- •Persons deprived of liberty by judicial or administrative decision and persons hospitalized without consent under Articles L. 3212-1 and L. 3213-1 who do not fall under the provisions of Article L. 1121-8, and persons admitted to a health or social institution for purposes other than research
- •Adults incapable or unable to express their consent (Article L1121-8 of the Public Health Code of "Code de Santé Publique")
- •Participant in the exclusion period of another biomedical research study
- •Participant who cannot be contacted in case of emergency
- •All categories of persons particularly protected under French law are excluded from this research (Articles L1121-5 to L1121-9 of the Public Health Code)
- •Employees at the Institut des Sciences de la Vision or EssilorLuxottica
- •Ocular pathology that may affect vision (e.g., glaucoma involving visual field loss, maculopathy involving visual acuity loss, or retinitis pigmentosa causing significant discomfort in poorly or overly lit environments)
- •Neurological deficit, including a history of epileptic pathology or regular or severe migraines
- •Ocular surgery affecting vision (e.g., refractive surgery, cataract surgery, or iridectomy)
- •Ocular or head trauma
研究组 & 干预措施
Glare discomfort measures with filters
Experimental
干预措施: Filter comparison (Other)
结局指标
主要结局
Light discomfort thresholds
时间窗: 2 hours
Amount of light (in lux) that produce a defined discomfort level (just perceptible or really disturbing)
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Filter Lenses for the Prevention of Migraine AttacksGlassesHeadacheVisual ImpairmentMigraineNCT06161129Rune Skovgaard Rasmussen200
已完成
2 期
Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic ConjunctivitisAllergic ConjunctivitisNCT02079649Alcon Research224
已完成
不适用
Filtered Eyewear to Prevent Light-induced Melatonin Suppression - Aim 1Sleep QualityNCT06310135Icahn School of Medicine at Mount Sinai29
已完成
不适用
Laser Vision Correction Use of an Eye Shield for Maintaining Vision and Mitigating PainPost Laser Vision Correction Pain and DiscomfortNCT01675375FORSIGHT Vision3125
已完成
2 期
A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD)Macular DegenerationWet Macular DegenerationNeovascular Age-related Macular DegenerationNCT05637255Sylentis, S.A.99